BCMA CAR-T for Dynamic High-risk Multiple Myeloma
Clinical trial NCT06880393 · RECRUITING
Trial details
- NCT number
- NCT06880393
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-18
- Primary completion
- 2027-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.